膜心脏病中的人工智能:创新和未来方向
Annette Maznyczka1, Rutger-Jan Nuis2, Isaac Shiri3
1Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom. Electronic address: https://twitter.com/AMaznyczka.
JACC. Cardiovascular interventions
|October 29, 2025
概括
人工智能 (AI) 可以通过分析复杂的数据来改善诊断,个性化治疗和更好的患者结果来提高心脏膜疾病 (VHD) 的管理. 严格的验证对于可靠的AI集成到临床实践中至关重要.
科学领域:
- 心脏病学 心脏病学
- 医疗信息学 医疗信息学
- 人工智能的人工智能
背景情况:
- 膜心脏病 (VHD) 管理需要整合多样化的患者数据,这使人类的认知能力受到压力.
- 越来越多的VHD数据体积和复杂性需要先进的分析工具.
研究的目的:
- 审查人工智能 (AI) 在管理膜心脏病 (VHD) 中的应用.
- 探索人工智能集成在VHD临床实践中的未来方向和挑战.
主要方法:
- 审查当前的AI应用,包括机器学习和深度学习,在VHD诊断和治疗.
- 讨论AI在风险预测,程序指导和个性化医疗数字双胞胎技术中的作用.
主要成果:
- 人工智能算法可以在常规调查 (心电图,心声图,CT) 中发现隐藏的模式,以预测风险.
- 人工智能增强了成像指导,以提高程序安全性和成功.
- 数字双胞胎技术使特定病例的疾病建模和不良事件预测成为可能.
结论:
- 人工智能为个性化VHD管理和改善临床结果提供了巨大的潜力.
- 严格的多中心验证,解决偏见,隐私和透明度,对于在医疗保健中采用AI至关重要.
相关概念视频
Heart Failure VI: Adjunct Therapies
246
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
246
Heart Valves
10.9K
The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
10.9K
Cardiomyopathy V: Interprofessional Care
331
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
331
Aortic Regurgitation III: Medical Management
388
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
388
Heart Failure V: Medical Management
209
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
209
Cardiomyopathy II: Dilated Cardiomyopathy
457
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
457


